Target intelligence / Profile preview

Bacterial 50S ribosomal subunit nascent peptide exit tunnel (NPET)

Target
NPET
Molecular classification
Ribonucleoprotein complex, Ribosome, Bacterial translation machinery
01

Overview

The bacterial 50S ribosomal subunit nascent peptide exit tunnel (NPET) is a structural channel that extends from the peptidyl transferase center (PTC) to the exterior of the large ribosomal subunit. Its primary biological function is to provide a protected path for the newly synthesized polypeptide chain to emerge from the ribosome during translation. The tunnel is not a passive conduit; its walls, composed mainly of 23S ribosomal RNA and specific ribosomal proteins like L4 and L22, interact with the nascent peptide to regulate translation speed and folding. In the context of infectious disease, the NPET is a major pharmacological target for several classes of antibiotics, including macrolides, lincosamides, and streptogramins. These drugs bind to specific sites within the tunnel, physically obstructing the exit of the peptide chain and causing the ribosome to stall. This inhibition of protein synthesis is bacteriostatic or bactericidal, making the NPET one of the most clinically significant targets in the treatment of Gram-positive and Gram-negative bacterial infections.

Other names
Ribosomal exit tunnel50S exit tunnelPolypeptide exit tunnelRibosomal tunnel
02

Mechanism of action

Inhibition of bacterial protein synthesis by sterically blocking the passage of the nascent polypeptide chain through the exit tunnel, leading to premature dissociation of peptidyl-tRNA from the ribosome.

03

Biological functions

Protein synthesisTranslationNascent peptide transportCo-translational protein folding
04

Disease associations

Bacterial infection
05

Safety considerations

Antibiotic resistance (e.g., rRNA methylation, efflux pumps)Mitochondrial ribosome cross-reactivity (mitochondrial toxicity)Gastrointestinal distressDrug-drug interactions (CYP3A4 inhibition by certain macrolides)
06

Interacting drugs

Erythromycin

9 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)erm gene expression (erythromycin resistance methylase)23S rRNA mutationsBacterial load reduction

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit nascent peptide exit tunnel (NPET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit nascent peptide exit tunnel (NPET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call